FDA lays out rules for regulating mobile medical apps

摘要

The FDA will not expect manufacturers to submit premarket review applications or to register and list mobile apps that ? Help users self-manage their disease or condition without providing specific treatment suggestions. ? Provide users simple tools to organize and track their health information. ? Provide easy access to information related to health conditions or treatments. ? Help patients document, show, or communicate potential medical conditions to health care professionals. ? Automate simple tasks for health care professionals. ? Enable patients or health care professionals to interact with personal health records or electronic health record systems.